Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention.

@article{DAscenzo2015MetaanalysisOR,
  title={Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention.},
  author={Fabrizio D'Ascenzo and Salma Taha and Claudio Moretti and Pierluigi Omed{\'e} and Walter Grossomarra and Jonas Persson and Morten Lamberts and Willem J.M. Dewilde and Andrea Rubboli and Sergio Aguilar Fernandez and Enrico Cerrato and Ilaria Meynet and Flavia Ballocca and Umberto Barbero and Giorgio Quadri and Francesca Giordana and Federico Conrotto and Davide Capodanno and James J Dinicolantonio and Sripal Bangalore and Matthew James Reed and Pascal Meier and Giuseppe G L Biondi Zoccai and Fiorenzo Gaita},
  journal={The American journal of cardiology},
  year={2015},
  volume={115 9},
  pages={
          1185-93
        }
}
The optimal antiaggregant therapy after coronary stenting in patients receiving oral anticoagulants (OACs) is currently debated. MEDLINE and Cochrane Library were searched for studies reporting outcomes of patients who underwent PCI and who were on triple therapy (TT) or dual-antiplatelet therapy (DAPT) with aspirin and clopidogrel or dual therapy (DT) with OAC and clopidogrel. Major bleeding was the primary end point, whereas all-cause death, myocardial infarction (MI), stent thrombosis, and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 citations